Global Epidemiology of Sexually Transmitted Diseases

Sexually Transmitted Diseases: Vaccines, Prevention, and Control

Volumn , Issue , 2012, Pages 3-43

  Mindel, Adrian ^a   Dwyer, Dominic ^b   Herring, Belinda ^b   Cunningham, Anthony L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85135549098     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-391059-2.00001-2     Document Type: Chapter

References (183)

1. Aboyeji A.P., Nwabuisi C. Prevalence of sexually transmitted diseases among pregnant women in Ilorin, Nigeria. J. Obstet. Gynaecol. 2003, 23(6):637-639.
2. Adler M.W. The terrible peril: a historical perspective on the venereal diseases. British Medical Journal 1980, 281:206-211.
3. Akahane Y., Kojima M., Sugai Y., Sakamoto M., Miyazaki Y., Tanaka T., et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann. Intern. Med. 1994, 120(9):748-752.
4. Alter M.J., Ahtone J., Weisfuse I., Starko K., Vacalis T.D., Maynard J.E. Hepatitis B virus transmission between heterosexuals. JAMA 1986, 256(10):1307-1310.
5. Andersson-Ellstrom A., Svennerholm B., Forssman L. Prevalence of antibodies to herpes simplex virus types 1 and 2, Epstein-Barr virus and cytomegalovirus in teenage girls. Scand J. Infect Dis. 1995, 27(4):315-318.
6. Aral S.O., Fenton K.A., Holmes K.K. Sexually transmitted diseases in the USA: temporal trends. Sex Transm. Infect. 2007, 83(4):257-266.
7. Aral S.O., Holmes K.K. Epidemiology of sexual behavior and sexually transmitted diseases. Sexually Transmitted Disease 1990, 19-36. McGraw Hill, New York. K.K. Holmes, P.A. Mirdh, P.J. Wiesner (Eds.).
8. Arbyn M., Dillner J. Review of current knowledge on HPV vaccination: an appendix to the European Guidelines for Quality Assurance in Cervical Cancer Screening. J. Clin. Virol. 2007, 38(3):189-197.
9. Bagossi P., Bander P., Bozoki B., Tozser J. Discovery and significance of new human T-lymphotropic viruses: HTLV-3 and HTLV-4. Expert Rev. Anti. Infect. Ther. 2009, 7(10):1235-1249.
10. Ballesteros J., Dal-Re R., Gonzalez A., del Romero J. Are homosexual males a risk group for hepatitis A infection in intermediate endemicity areas?. Epidemiol. Infect. 1996, 117(1):145-148.
11. Barre-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220(4599):868-871.
12. Beasley R.P., Hwang L.Y., Lee G.C., Lan C.C., Roan C.H., Huang F.Y., et al. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983, 2(8359):1099-1102.
13. Berris B., Wrobel D.M., Sinclair J.C., Feinman S.V. Hepatitis B antigen in families of blood donors. Ann. Intern. Med. 1973, 79(5):690-693.
14. Biraro S., Mayaud P., Morrow R.A., Grosskurth H., Weiss H.A. Performance of commercial herpes simplex virus type-2 antibody tests using serum samples from sub-Saharan Africa: a systematic review and meta-analysis. Sex Transm. Dis. 2011, 38(2):140-147.
15. Boeckh M., Geballe A.P. Cytomegalovirus: pathogen, paradigm, and puzzle. J. Clin. Invest. 2011, 121(5):1673-1680.
16. Bosch F.X., Burchell A.N., Schiffman M., Giuliano A.R., de Sanjose S., Bruni L., et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008, 26(Suppl. 10):K1-16.
17. Boshoff C., Weiss R. AIDS-related malignancies. Nat. Rev. Cancer 2002, 2(5):373-382.
18. Bresters D., Mauser-Bunschoten E.P., Reesink H.W., Roosendaal G., van der Poel C.L., Chamuleau R.A., et al. Sexual transmission of hepatitis C virus. Lancet 1993, 342(8865):210-211.
19. Brettler D.B., Mannucci P.M., Gringeri A., Rasko J.E., Forsberg A.D., Rumi M.G., et al. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: an international, multicenter study. Blood 1992, 80(2):540-543.
20. Brouwer K.C., Strathdee S.A., Magis-Rodriguez C., Bravo-Garcia E., Gayet C., Patterson T.L., et al. Estimated numbers of men and women infected with HIV/AIDS in Tijuana, Mexico. J. Urban Health 2006, 83(2):299-307.
21. Brown D.R., Schroeder J.M., Bryan J.T., Stoler M.H., Fife K.H. Detection of multiple human papillomavirus types in condylomata acuminata lesions from otherwise healthy and immunosuppressed patients. J. Clin. Microbiol. 1999, 37(10):3316-3322.
22. Bruni L., Diaz M., Castellsague X., Ferrer E., Bosch F.X., de Sanjose S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J. Infect Dis. 2010, 202(12):1789-1799.
23. Calattini S., Chevalier S.A., Duprez R., Bassot S., Froment A., Mahieux R., et al. Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa. Retrovirology 2005, 2:30.
24. Campbell-Yesufu O.T., Gandhi R.T. Update on human immunodeficiency virus (HIV)-2 infection. Clin. Infect. Dis. 2011, 52(6):780-787.
25. Casoli C., Pilotti E., Bertazzoni U. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression. AIDS Rev. 2007, 9(3):140-149.
26. Centers for Disease Control Leads from the MMWR. Changing patterns of groups at high risk for hepatitis B in the United States. JAMA 1988, 260(6). 761, 765, 770.
27. Centers for Disease Control and Prevention Hepatitis A among homosexual men - United States, Canada and Australia. MMWR 1992, 41:161-164.
28. Centers for Disease Control and Prevention Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years-United States, 2005-2008. MMWR Morb. Mortal. Wkly Rep. 2010, 59(15):456-459.
29. Centers for Disease Control and Prevention Sexually Transmitted Disease Surveillance 2009 2010, Retrieved from. http://www.cdc.gov/std/stats09/surv2009-Complete.pdf.
30. Centers for Disease Control and Prevention Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex with Men - New York City, 2005-2010. MMWR 2011, 60(28):945-950.
31. Centers for Disease Control and Prevention, Division of STD/HIV Prevention Sexually Transmitted Disease Surveillance, 1993 1994, Retrieved from. http://wonder.cdc.gov/wonder/STD/OSTD3006.PCW.html.
32. Chant K., Lowe D., Rubin G., Manning W., O'Donoughue R., Lyle D., et al. Patient-to-patient transmission of HIV in private surgical consulting rooms. Lancet 1993, 342(8886-8887):1548-1549.
33. Chen Z.Q., Zhang G.C., Gong X.D., Lin C., Gao X., Liang G.J., et al. Syphilis in China: results of a national surveillance programme. Lancet 2007, 369(9556):132-138.
34. Christenson B., Brostrom C., Bottiger M., Hermanson J., Weiland O., Ryd G., et al. An epidemic outbreak of hepatitis A among homosexual men in Stockholm. Hepatitis A, a special hazard for the male homosexual subpopulation in Sweden. Am. J. Epidemiol. 1982, 116(4):599-607.
35. Coelho H.C., Perdona G.C., Neves F.R., Passos A.D. HIV prevalence and risk factors in a Brazilian penitentiary. Cad. Saude Publica. 2007, 23(9):2197-2204.
36. Coghlan B. HIV in the Pacific: 1984-2007 2008, Burnet Institute, East Melbourne.
37. Cohen M.S., Henderson G.E., Aiello P., Zheng H. Successful eradication of sexually transmitted diseases in the People's Republic of China: implications for the 21st century. J. Infect Dis. 1996, 174(Suppl. 2):S223-S229.
38. Collier A.C., Handsfield H.H., Ashley R., Roberts P.L., DeRouen T., Meyers J.D., et al. Cervical but not urinary excretion of cytomegalovirus is related to sexual activity and contraceptive practices in sexually active women. J. Infect. Dis. 1995, 171(1):33-38.
39. Corey L., Wald A. Maternal and neonatal herpes simplex virus infections. N. Engl. J. Med. 2009, 361(14):1376-1385.
40. Corona R., Caprilli F., Giglio A., Stroffolini T., Tosti M.E., Gentili G., et al. Risk factors for hepatitis B virus infection among heterosexuals attending a sexually transmitted diseases clinic in Italy: role of genital ulcerative diseases. J. Med. Virol. 1996, 48(3):262-266.
41. Coutinho R.A., Albrecht-van Lent P., Lelie N., Nagelkerke N., Kuipers H., Rijsdijk T. Prevalence and incidence of hepatitis A among male homosexuals. Br. Med. J. (Clin. Res. Ed.) 1983, 287(6407):1743-1745.
42. Cunningham A.L., Lee F.K., Ho D.W., Field P.R., Law C.L., Packham D.R., et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med. J. Aust. 1993, 158(8):525-528.
43. Cunningham A.L., Taylor R., Taylor J., Marks C., Shaw J., Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm. Infect. 2006, 82(2):164-168.
44. Cutts F.T., Franceschi S., Goldie S., Castellsague X., de Sanjose S., Garnett G., et al. Human papillomavirus and HPV vaccines: a review. Bull. World Health Organ. 2007, 85(9):719-726.
45. Cwikel J.G., Lazer T., Press F., Lazer S. Sexually transmissible infections among female sex workers: an international review with an emphasis on hard-to-access populations. Sex Health 2008, 5(1):9-16.
46. Da Villa G., Romano L., Sepe A., Iorio R., Paribello N., Zappa A., et al. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals. Vaccine 2007, 25(16):3133-3136.
47. De Cock K.M., Niland J.C., Lu H.P., Rahimian A., Edwards V., Shriver K., et al. Experience with human immunodeficiency virus infection in patients with hepatitis B virus and hepatitis delta virus infections in Los Angeles, 1977-1985. Am. J. Epidemiol. 1988, 127(6):1250-1260.
48. de The G., Bomford R. An HTLV-I vaccine: why, how, for whom?. AIDS Res. Hum. Retroviruses 1993, 9(5):381-386.
49. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324(1):17-27.
50. Delpech V., Martin I.M., Hughes G., Nichols T., James L., Ison C.A. Epidemiology and clinical presentation of gonorrhoea in England and Wales: findings from the Gonococcal Resistance to Antimicrobials Surveillance Programme 2001-2006. Sex Transm. Infect. 2009, 85(5):317-321.
51. Diamond C., Thiede H., Perdue T., MacKellar D., Valleroy L.A., Corey L. Seroepidemiology of human herpesvirus 8 among young men who have sex with men. Sex Transm. Dis. 2001, 28(3):176-183.
52. Dienstag J.L. Sexual and perinatal transmission of hepatitis C. Hepatology 1997, 26(3 Suppl. 1):66S-70S.
53. Doi Y., Ninomiya T., Hata J., Yonemoto K., Tanizaki Y., Arima H., et al. Seroprevalence of herpes simplex virus 1 and 2 in a population-based cohort in Japan. J. Epidemiol. 2009, 19(2):56-62.
54. Donovan B., Franklin N., Guy R., Grulich A.E., Regan D.G., Ali H., et al. Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data. Lancet Infect. Dis. 2011, 11(1):39-44.
55. Dunn R.A., Rolfs R.T. The resurgence of syphilis in the United States. Current Opinion in Infectious Diseases 1991, 4:3-11.
56. Eberhart-Phillips J., Dickson N.P., Paul C., Fawcett J.P., Holland D., Taylor J., et al. Herpes simplex type 2 infection in a cohort aged 21 years. Sex Transm. Infect. 1998, 74(3):216-218.
57. el-Dalil A.A., Jayaweera D.T., Walzman M., Radcliffe K.W., Richmond R., Wade A.A., et al. Hepatitis B markers in heterosexual patients attending two genitourinary medicine clinics in the West Midlands. Genitourin. Med. 1997, 73(2):127-130.
58. Embil J.A., Garner J.B., Pereira L.H., White F.M., Manuel F.R. Association of cytomegalovirus and herpes simplex virus infections of the cervix in four clinic populations. Sex Transm. Dis. 1985, 12(4):224-228.
59. Eyster M.E., Alter H.J., Aledort L.M., Quan S., Hatzakis A., Goedert J.J. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann. Intern. Med. 1991, 115(10):764-768.
60. Fenton K.A., Lowndes C.M. Recent trends in the epidemiology of sexually transmitted infections in the European Union. Sex Transm. Infect. 2004, 80(4):255-263.
61. Fleming D.T., McQuillan G.M., Johnson R.E., Nahmias A.J., Aral S.O., Lee F.K., et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 1997, 337(16):1105-1111.
62. Freedman E., Britt H., Harrison C.M., Mindel A. Sexual health problems managed in Australian general practice: a national, cross sectional survey. Sex Transm. Infect. 2006, 82(1):61-66.
63. Freeman E.E., Weiss H.A., Glynn J.R., Cross P.L., Whitworth J.A., Hayes R.J. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006, 20(1):73-83.
64. Fulford K.W., Dane D.S., Catterall R.D., Woof R., Denning J.V. Australia antigen and antibody among patients attending a clinic for sexually transmitted diseases. Lancet 1973, 1(7818):1470-1473.
65. Ganczak M., Barss P. Nosocomial HIV infection: epidemiology and prevention-a global perspective. AIDS Rev. 2008, 10(1):47-61.
66. Gerbase A.C., Rowley J.T., Heymann D.H., Berkley S.F., Piot P. Global prevalence and incidence estimates of selected curable STDs. Sex Transm. Infect. 1998, 74(Suppl. 1):S12-S16.
67. Giuliano A.R., Tortolero-Luna G., Ferrer E., Burchell A.N., de Sanjose S., Kjaer S.K., et al. Epidemiology of human papillomavirus infection in men, cancers other than cervical and benign conditions. Vaccine 2008, 26(Suppl. 10):K17-K28.
68. Görander S., Lagergård T., Romanik M., Viscidi R.P., Martirosian G., Liljeqvist J.A. Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice. Poland. Clin. Vaccine Immunol. 2008, 15(4):675-680.
69. Gordon S.C., Patel A.H., Kulesza G.W., Barnes R.E., Silverman A.L. Lack of evidence for the heterosexual transmission of hepatitis C. Am. J. Gastroenterol. 1992, 87(12):1849-1851.
70. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346(8974):530-536.
71. Haddow L.J., Dave B., Mindel A., McPhie K.A., Chung C., Marks C., et al. Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003. Sex Transm. Infect. 2006, 82(3):255-259.
72. Hall H.I., Song R., Rhodes P., Prejean J., An Q., Lee L.M., et al. Estimation of HIV incidence in the United States. JAMA 2008, 300(5):520-529.
73. Harpaz R., McMahon B.J., Margolis H.S., Shapiro C.N., Havron D., Carpenter G., et al. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program. J. Infect. Dis. 2000, 181(2):413-418.
74. Hart G. Donovanosis. Clin. Infect Dis. 1997, 25(1):24-30. quiz 31-22.
75. Health Protection Agency STI Annual data tables 2011, Retrieved 8 August, 2011, from. http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1247816547927.
76. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011, 25(5):679-689.
77. Heng B.H., Goh K.T., Chan R., Chew S.K., Doraisingham S., Quek G.H. Prevalence of hepatitis B virus (HBV) infection in Singapore men with sexually transmitted diseases and HIV infection: role of sexual transmission in a city state with intermediate HBV endemicity. J. Epidemiol Community Health 1995, 49(3):309-313.
78. Henning K.J., Bell E., Braun J., Barker N.D. A community-wide outbreak of hepatitis A: risk factors for infection among homosexual and bisexual men. Am. J. Med. 1995, 99(2):132-136.
79. Higgins C.D., Swerdlow A.J., Macsween K.F., Harrison N., Williams H., McAulay K., et al. A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J. Infect. Dis. 2007, 195(4):474-482.
80. Hill J.B., Sheffield J.S., Kim M.J., Alexander J.M., Sercely B., Wendel G.D. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstetrics and Gynecology 2002, 99(6):1049-1052.
81. Hlela C., Shepperd S., Khumalo N.P., Taylor G.P. The prevalence of human T-cell lymphotropic virus type 1 in the general population is unknown. AIDS Rev. 2009, 11(4):205-214.
82. Ho D.D. Perspectives series: host/pathogen interactions. Dynamics of HIV-1 replication in vivo. The Journal of Clinical Investigation 1997, 99(11):2565-2567.
83. Ho D.W., Field P.R., Irving W.L., Packham D.R., Cunningham A.L. Detection of immunoglobulin M antibodies to glycoprotein G-2 by western blot (immunoblot) for diagnosis of initial herpes simplex virus type 2 genital infections. J. Clin. Microbiol. 1993, 31(12):3157-3164.
84. Ho D.W., Field P.R., Sjogren-Jansson E., Jeansson S., Cunningham A.L. Indirect ELISA for the detection of HSV-2 specific IgG and IgM antibodies with glycoprotein G (gG-2). J. Virol. Methods 1992, 36(3):249-264.
85. Ibe S., Yokomaku Y., Shiino T., Tanaka R., Hattori J., Fujisaki S., et al. HIV-2 CRF01_AB: first circulating recombinant form of HIV-2. J. Acquir Immune Defic. Syndr. 2010, 54(3):241-247.
86. Jacobs B., Mayaud P., Changalucha J., Todd J., Ka-Gina G., Grosskurth H., et al. Sexual transmission of hepatitis B in Mwanza, Tanzania. Sex Transm. Dis. 1997, 24(3):121-126.
87. Jacobsen K.H., Wiersma S.T. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine 2010, 28(41):6653-6657.
88. Jayaraman S., Chalabi Z., Perel P., Guerriero C., Roberts I. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 2010, 50(2):433-442.
89. Jebbari H., Alexander S., Ward H., Evans B., Solomou M., Thornton A., et al. Update on lymphogranuloma venereum in the United Kingdom. Sex Transm. Infect. 2007, 83(4):324-326.
90. Johnson R.E., Nahmias A.J., Magder L.S., Lee F.K., Brooks C.A., Snowden C.B. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N. Engl. J. Med. 1989, 321(1):7-12.
91. Jonassen T.O., Stene-Johansen K., Berg E.S., Hungnes O., Lindboe C.F., Froland S.S., et al. Sequence analysis of HIV-1 group O from Norwegian patients infected in the 1960s. Virology 1997, 231(1):43-47.
92. Juarez-Figueroa L.A., Uribe-Salas F.J., Conde-Glez C.J., Hernandez-Avila M., Hernandez-Nevarez P., Uribe-Zuniga P., et al. Hepatitis B markers in men seeking human immunodeficiency virus antibody testing in Mexico City. Sex Transm. Dis. 1997, 24(4):211-217.
93. Kamali A., Quigley M., Nakiyingi J., Kinsman J., Kengeya-Kayondo J., Gopal R., et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003, 361(9358):645-652.
94. Karayiannis P., Novick D.M., Lok A.S., Fowler M.J., Monjardino J., Thomas H.C. Hepatitis B virus DNA in saliva, urine, and seminal fluid of carriers of hepatitis B e antigen. Br. Med. J. (Clin. Res. Ed.) 1985, 290(6485):1853-1855.
95. Katz M.H., Hsu L., Wong E., Liska S., Anderson L., Janssen R.S. Seroprevalence of and risk factors for hepatitis A infection among young homosexual and bisexual men. J. Infect. Dis. 1997, 175(5):1225-1229.
96. Klint M., Hadad R., Christerson L., Lore B., Anagrius C., Osterlund A., et al. Prevalence trends in Sweden for the new variant of Chlamydia trachomatis. Clin. Microbiol. Infect. 2011, 17(5):683-689.
97. Koutsky L.A., Galloway D.A., Holmes K.K. Epidemiology of genital human papillomavirus infection. Epidemiol. Rev. 1988, 10:122-163.
98. Koutsky L.A., Stevens C.E., Holmes K.K., Ashley R.L., Kiviat N.B., Critchlow C.W., et al. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures. N. Engl. J. Med. 1992, 326(23):1533-1539.
99. Krieger J.N., Coombs R.W., Collier A.C., Ross S.O., Speck C., Corey L. Seminal shedding of human immunodeficiency virus type 1 and human cytomegalovirus: evidence for different immunologic controls. J. Infect. Dis. 1995, 171(4):1018-1022.
100. Lai W., Chen C.Y., Morse S.A., Htun Y., Fehler H.G., Liu H., et al. Increasing relative prevalence of HSV-2 infection among men with genital ulcers from a mining community in South Africa. Sex Transm. Infect. 2003, 79(3):202-207.
101. Lattimore S., Yin Z., Logan L., Rice B., Thornton A., Molinar D., et al. Situation of HIV infections and STIs in the United Kingdom in 2007. Euro. Surveill. 2008, 13(49).
102. Leentvaar-Kuijpers A., Kool J.L., Veugelers P.J., Coutinho R.A., van Griensven G.J. An outbreak of hepatitis A among homosexual men in Amsterdam, 1991-1993. Int. J. Epidemiol. 1995, 24(1):218-222.
103. Looker K.J., Garnett G.P., Schmid G.P. An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection. Bull. World Health Organ. 2008, 86(10). 805-812A.
104. Mahieux R., Gessain A. The human HTLV-3 and HTLV-4 retroviruses: new members of the HTLV family. Pathol. Biol. (Paris) 2009, 57(2):161-166.
105. Mathers B.M., Degenhardt L., Phillips B., Wiessing L., Hickman M., Strathdee S.A., et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet 2008, 372(9651):1733-1745.
106. Mathijs J.M., Rawlinson W.D., Jacobs S., Bilous A.M., Milliken J.S., Dowton D.N., et al. Cellular localization of human cytomegalovirus reactivation in the cervix. J. Infect. Dis. 1991, 163(4):921-922.
107. Maupas P., Melnick J.L. Hepatitis B infection and primary liver cancer. Prog. Med. Virol. 1981, 27:1-5.
108. McCutchan F.E. Understanding the genetic diversity of HIV-1. AIDS 2000, 14(Suppl. 3):S31-S44.
109. McCutchan F.E. Global epidemiology of HIV. J. Med. Virol. 2006, 78(Suppl. 1):S7-S12.
110. Meheus A., De Schryver A. Sexually transmitted diseases in developing countries. Current Opinion in Infectious Diseases 1989, 2:25-30.
111. Meisel H., Reip A., Faltus B., Lu M., Porst H., Wiese M., et al. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet 1995, 345(8959):1209-1211.
112. Melbye M., Biggar R.J., Wantzin P., Krogsgaard K., Ebbesen P., Becker N.G. Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. BMJ 1990, 301(6745):210-212.
113. Menendez C., Castellsague X., Renom M., Sacarlal J., Quinto L., Lloveras B., et al. Prevalence and risk factors of sexually transmitted infections and cervical neoplasia in women from a rural area of southern Mozambique. Infect. Dis. Obstet. Gynecol. 2010, 2010.
114. Mepham S.O., Bland R.M., Newell M.L. Prevention of mother-to-child transmission of HIV in resource-rich and -poor settings. BJOG 2011, 118(2):202-218.
115. Mertz G.J., Benedetti J., Ashley R., Selke S.A., Corey L. Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 1992, 116(3):197-202.
116. Mindel A., Sutherland S. Antibodies to cytomegalovirus in homosexual and heterosexual men attending an STD clinic. Br. J. Vener. Dis. 1984, 60(3):189-192.
117. Mindel A., Tovey S.J., Williams P. Primary and secondary syphilis, 20 years' experience. 1. Epidemiology. Genitourin. Med. 1987, 63(6):361-364.
118. Mulhall B.P., Hart G., Harcourt C. Sexually transmitted diseases in Australia: a decade of change. Epidemiology and surveillance. Ann. Acad. Med. Singapore 1995, 24(4):569-578.
119. Mullick S., Watson-Jones D., Beksinska M., Mabey D. Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm. Infect. 2005, 81(4):294-302.
120. Nandwani R., Caswell S., Boag F., Lawrence A.G., Coleman J.C. Hepatitis A seroprevalence in homosexual and heterosexual men. Genitourin. Med. 1994, 70(5):325-328.
121. Nelson P.K., Mathers B.M., Cowie B., Hagan H., Des Jarlais D., Horyniak D., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011, 378(9791):571-583.
122. Obasi A., Mosha F., Quigley M., Sekirassa Z., Gibbs T., Munguti K., et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J. Infect. Dis. 1999, 179(1):16-24.
123. Osmond D.H., Padian N.S., Sheppard H.W., Glass S., Shiboski S.C., Reingold A. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA 1993, 269(3):361-365.
124. Parkin D.M., Nambooze S., Wabwire-Mangen F., Wabinga H.R. Changing cancer incidence in Kampala, Uganda, 1991-2006. Int. J. Cancer 2010, 126(5):1187-1195.
125. Paz-Bailey G., Rahman M., Chen C., Ballard R., Moffat H.J., Kenyon T., et al. Changes in the etiology of sexually transmitted diseases in Botswana between 1993 and 2002: implications for the clinical management of genital ulcer disease. Clin. Infect. Dis. 2005, 41(9):1304-1312.
126. Paz-Bailey G., Ramaswamy M., Hawkes S.J., Geretti A.M. Herpes simplex virus type 2: epidemiology and management options in developing countries. Sex Transm. Infect. 2007, 83(1):16-22.
127. Pebody R.G., Andrews N., Brown D., Gopal R., De Melker H., Francois G., et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm. Infect. 2004, 80(3):185-191.
128. Perkins H.A., Busch M.P. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress. Transfusion 2010, 50(10):2080-2099.
129. Perkins N.L., Coughlan E.P., Franklin R.A., Reid M.R., Taylor J. Seroprevalence of herpes simplex virus type 2 antibodies in New Zealand sexual health clinic patients. N. Z. Med. J. 1996, 109(1032):402-405.
130. Perrin L., Kaiser L., Yerly S. Travel and the spread of HIV-1 genetic variants. Lancet Infect Dis. 2003, 3(1):22-27.
131. Peters M.G. Special populations with hepatitis B virus infection. Hepatology 2009, 49(Suppl. 5):S146-S155.
132. Poiesz B.J., Ruscetti F.W., Gazdar A.F., Bunn P.A., Minna J.D., Gallo R.C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. U S A. 1980, 77(12):7415-7419.
133. Proietti F.A., Carneiro-Proietti A.B., Catalan-Soares B.C., Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 2005, 24(39):6058-6068.
134. Rall C.J., Dienstag J.L. Epidemiology of hepatitis C virus infection. Semin Gastrointest Dis. 1995, 6(1):3-12.
135. Reynolds S.J., Quinn T.C. Developments in STD/HIV interactions: the intertwining epidemics of HIV and HSV-2. Infect. Dis. Clin. North Am. 2005, 19(2):415-425.
136. Robertson D.L., Anderson J.P., Bradac J.A., Carr J.K., Foley B., Funkhouser R.K., et al. HIV-1 nomenclature proposal. Science 2000, 288(5463):55-56.
137. Robertson D.L., Sharp P.M., McCutchan F.E., Hahn B.H. Recombination in HIV-1. Nature 1995, 374(6518):124-126.
138. Rode O.D., Lepej S.Z., Begovac J. Seroprevalence of herpes simplex virus type 2 in adult HIV-infected patients and blood donors in Croatia. Coll. Antropol. 2008, 32(3):693-695.
139. Rosenthal S.L., Stanberry L.R., Biro F.M., Slaoui M., Francotte M., Koutsoukos M., et al. Seroprevalence of herpes simplex virus types 1 and 2 and cytomegalovirus in adolescents. Clin. Infect. Dis. 1997, 24(2):135-139.
140. Schmid G., Rowley J., Samuelson J., Tiun Y., Giriab M., Mathers C., et al. World Health Organization (WHO) 2005 Global Estimates of the Incidence and Prevalence of Sexually Transmitted Infections. Paper presented at the 18th ISSTDR 2009.
141. Schreeder M.T., Thompson S.E., Hadler S.C., Berquist K.R., Zaidi A., Maynard J.E., et al. Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J. Infect. Dis. 1982, 146(1):7-15.
142. Scott-Wright A., Hakre S., Bryan J.P., Jaramillo R., Reyes L.G., Cruess D., et al. Hepatitis B virus, human immunodeficiency virus type-1, and syphilis among women attending prenatal clinics in Belize, Central America. Am. J. Trop. Med. Hyg. 1997, 56(3):285-290.
143. Sen P., Chio M.T., Tan H.H., Chan R.K. Rising trends of STIs and HIV infection in Singapore - a review of epidemiology over the last 10 years (1994 to 2003). Ann. Acad. Med. Singapore 2006, 35(4):229-235.
144. Sfetcu O., Irvine N., Ngui S.L., Emerson C., McCaughey C., Donaghy P. Hepatitis A outbreak predominantly affecting men who have sex with men in Northern Ireland, October 2008 to July 2009. Euro Surveill. 2011, 16(9).
145. Shepard C.W., Simard E.P., Finelli L., Flore A.E., Bell B.P. Hepatitis B virus infection: Epidemiology and vaccination. Epidemiologic Reviews 2006, 28:112-125.
146. Shores N.J., Maida I., Soriano V., Nunez M. Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients. J. Hepatol. 2008, 49(3):323-328.
147. Slattery J.P., Franchini G., Gessain A. Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. Genome Res. 1999, 9(6):525-540.
148. Smittskyddsinstitutet (SMI) Chlamydia infection 2011, Retrieved 8 August, 2011, from. http://www.smittskyddsinstitutet.se/in-english/statistics/chlamydia-infection-/%23statistics-nav.
149. Smith J.S., Robinson N.J. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 2002, 186(Suppl. 1):S3-28.
150. Sonoda S., Li H.C., Tajima K. Ethnoepidemiology of HTLV-1 related diseases: ethnic determinants of HTLV-1 susceptibility and its worldwide dispersal. Cancer Sci. 2011, 102(2):295-301.
151. Stabinski L., Reynolds S.J., Ocama P., Laeyendecker O., Serwadda D., Gray R.H., et al. Hepatitis B virus and sexual behavior in Rakai, Uganda. J. Med. Virol. 2011, 83(5):796-800.
152. Stadler L.P., Bernstein D.I., Callahan S.T., Ferreira J., Gorgone Simone G.A., Edwards K.M., et al. Seroprevalence of cytomegalovirus (CMV) and risk factors for infection in adolescent males. Clin. Infect. Dis. 2010, 51(10):e76-e81.
153. Staras S.A., Flanders W.D., Dollard S.C., Pass R.F., McGowan J.E., Cannon M.J. Influence of sexual activity on cytomegalovirus seroprevalence in the United States, 1988-1994. Sex Transm. Dis. 2008, 35(5):472-479.
154. Sullivan E.A., Abel M., Tabrizi S., Garland S.M., Grice A., Poumerol G., et al. Prevalence of sexually transmitted infections among antenatal women in Vanuatu, 1999-2000. Sex Transm. Dis. 2003, 30(4):362-366.
155. Sullivan P.S., Hamouda O., Delpech V., Geduld J.E., Prejean J., Semaille C., et al. Reemergence of the HIV epidemic among men who have sex with men in North America, Western Europe, and Australia, 1996-2005. Ann. Epidemiol. 2009, 19(6):423-431.
156. Suntoke T.R., Hardick A., Tobian A.A., Mpoza B., Laeyendecker O., Serwadda D., et al. Evaluation of multiplex real-time PCR for detection of Haemophilus ducreyi, Treponema pallidum, herpes simplex virus type 1 and 2 in the diagnosis of genital ulcer disease in the Rakai District, Uganda. Sex Transm. Infect. 2009, 85(2):97-101.
157. Takebe Y., Uenishi R., Li X. Global molecular epidemiology of HIV: understanding the genesis of AIDS pandemic. Adv. Pharmacol. 2008, 56:1-25.
158. Tebit D.M., Arts E.J. Tracking a century of global expansion and evolution of HIV to drive understanding and to combat disease. Lancet Infect. Dis. 2011, 11(1):45-56.
159. Thomas D.L., Zenilman J.M., Alter H.J., Shih J.W., Galai N., Carella A.V., et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore-an analysis of 309 sex partnerships. J. Infect. Dis. 1995, 171(4):768-775.
160. Thomas R., Macsween K.F., McAulay K., Clutterbuck D., Anderson R., Reid S., et al. Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions. J. Med. Virol. 2006, 78(9):1204-1209.
161. Thorne C., Ferencic N., Malyuta R., Mimica J., Niemiec T. Central Asia: hotspot in the worldwide HIV epidemic. Lancet Infect. Dis. 2010, 10(7):479-488.
162. Tichonova L., Borisenko K., Ward H., Meheus A., Gromyko A., Renton A. Epidemics of syphilis in the Russian Federation: trends, origins, and priorities for control. Lancet 1997, 350:210-213.
163. Torres J.R. Hepatitis B and hepatitis delta virus infection in South America. Gut 1996, 38(Suppl. 2):S48-S55.
164. Tronstein E., Johnston C., Huang M.L., Selke S., Magaret A., Warren T., et al. Genital shedding of herpes simplex virus among symptomatic and asymptomatic persons with HSV-2 infection. JAMA 2011, 305(14):1441-1449.
165. Tucker J.D., Chen X.S., Peeling R.W. Syphilis and social upheaval in China. N. Engl. J. Med. 2010, 362(18):1658-1661.
166. UNAIDS Global Report:UNAIDS report on the global AIDS epidemic 2010 2010.
167. United Nations We Can End Poverty 2015 Millenium Development Goals 2000, Retrieved 8 August, 2011, from. http://www.un.org/millenniumgoals/bkgd.shtml.
168. van Baarle D., Hovenkamp E., Dukers N.H., Renwick N., Kersten M.J., Goudsmit J., et al. High prevalence of Epstein-Barr virus type 2 among homosexual men is caused by sexual transmission. J. Infect. Dis. 2000, 181(6):2045-2049.
169. van de Laar M.J., Likatavicius G. HIV and AIDS in the European Union, 2008. Euro. Surveill. 2009, 14(47).
170. Van der Bij A.K., Spaargaren J., Morre S.A., Fennema H.S., Mindel A., Coutinho R.A., et al. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. Clin. Infect. Dis. 2006, 42(2):186-194.
171. van der Helm J.J., Prins M., del Amo J., Bucher H.C., Chene G., Dorrucci M., et al. The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS 2011, 25(8):1083-1091.
172. Verdonck K., Gonzalez E., Van Dooren S., Vandamme A.M., Vanham G., Gotuzzo E. Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect. Dis. 2007, 7(4):266-281.
173. Wald A., Corey L., Cone R., Hobson A., Davis G., Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J. Clin. Invest. 1997, 99(5):1092-1097.
174. Wald A., Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J. Infect. Dis. 2002, 185(1):45-52.
175. Wang J.S., Zhu Q.R., Wang X.H. Breastfeeding does not pose any additional risk of immunoprophylaxis failure on infants of HBV carrier mothers. International Journal of Clinical Practice 2003, 57(2):100-102.
176. Wasley A., Fiore A., Bell B.P. Hepatitis A in the era of vaccination. Epidemiol. Rev. 2006, 28:101-111.
177. Wawer M.J., Sewankambo N.K., Serwadda D., Quinn T.C., Paxton L.A., Kiwanuka N., et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 1999, 353(9152):525-535.
178. Wolfe N.D., Heneine W., Carr J.K., Garcia A.D., Shanmugam V., Tamoufe U., et al. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc. Natl. Acad. Sci. U. S. A. 2005, 102(22):7994-7999.
179. World Health Organization International Agency for Research on Cancer Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum. 2007, 90:1-636.
180. Yoshida M., Miyoshi I., Hinuma Y. A retrovirus from human leukemia cell lines: its isolation, characterization, and implication in human adult T-cell leukemia (ATL). Princess Takamatsu Symp. 1982, 12:285-294.
181. Zanetti A.R., Van Damme P., Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 2008, 26(49):6266-6273.
182. Zheng H., Wolfe N.D., Sintasath D.M., Tamoufe U., Lebreton M., Djoko C.F., et al. Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon. Virology 2010, 401(2):137-145.
183. Zhu T., Korber B.T., Nahmias A.J., Hooper E., Sharp P.M., Ho D.D. An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature 1998, 391(6667):594-597.